MEDIUMRegulatoryTier 1

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

SourceFDA RecallsTier 1Hard News

By FDA

Originally at fda.gov

Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.

Why it matters for dental

Dentists who administer injectable glutathione (e.g., for adjunctive anti-oxidant or adjunctive periodontal protocols) must quarantine the affected Optimal Balance Pharmacy lot immediately to avoid potential endotoxin-related febrile or septic events in-office.

Key points

  • Recall targets Compounded Glutathione 200 mg/mL, 30 mL multi-dose vials from Optimal Balance Pharmacy (Houston, TX) due to confirmed elevated endotoxin levels.
  • Distribution is nationwide and recall is to the patient level, meaning any clinic inventory or dispensed doses must be returned or destroyed.
  • Endotoxin exposure risk includes fever, chills, or septic shock; dental practices using compounded injectables for in-office procedures should verify lot numbers against their supplier records.
  • No other glutathione products or other Optimal Balance compounded items are included in this action.

Who should care

OwnerAssociateSpecialist

Read the original on FDA Recalls

Full reporting and any paywall content live on fda.gov. We summarize and score; we do not republish.

Open original

Related